These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38438972)

  • 1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of web
    Zhan G; Cao P; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
    Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
    BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
    Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
    BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
    Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
    Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
    Shen J; Zhou Y; Yu B; Zhao K; Ding Y
    Eur J Surg Oncol; 2023 Oct; 49(10):106966. PubMed ID: 37365056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.
    Huang G; Lin Q; Yin P; Mao K; Zhang J
    Cancer Med; 2023 Jun; 12(12):13167-13181. PubMed ID: 37102245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
    Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
    BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.
    He T; Chen T; Liu X; Zhang B; Yue S; Cao J; Zhang G
    Front Public Health; 2021; 9():789026. PubMed ID: 35096742
    [No Abstract]   [Full Text] [Related]  

  • 12. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
    Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
    Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study.
    Wang L; Peng JL; Wu JZ
    Medicine (Baltimore); 2023 Mar; 102(13):e33319. PubMed ID: 37000113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
    Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival prediction in hepatocellular carcinoma: development and validation of a novel nomogram based on the SEER database.
    Huang S; Zhu Z; Ruan Y; Zhang F; Xu Y; Jin L; Lopez-Lopez V; Merle P; Lu G; Li L
    J Gastrointest Oncol; 2023 Aug; 14(4):1817-1829. PubMed ID: 37720431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma.
    Wen C; Tang J; Luo H
    Front Public Health; 2022; 10():848716. PubMed ID: 35296046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
    Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
    J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.